APA (7th ed.) Citation

T, H., H, H., Y, T., R, Y., K, M., M, M., . . . T, T. (2026). On-treatment viral factors affect subsequent hepatitis B surface antigen seroclearance in patients treated with nucleos(t)ide analogs for > 10 years. Journal of gastroenterology, 61(7), 990. https://doi.org/10.1007/s00535-026-02415-3

Chicago Style (17th ed.) Citation

T, Hosaka, et al. "On-treatment Viral Factors Affect Subsequent Hepatitis B Surface Antigen Seroclearance in Patients Treated with Nucleos(t)ide Analogs For > 10 years." Journal of Gastroenterology 61, no. 7 (2026): 990. https://doi.org/10.1007/s00535-026-02415-3.

MLA (9th ed.) Citation

T, Hosaka, et al. "On-treatment Viral Factors Affect Subsequent Hepatitis B Surface Antigen Seroclearance in Patients Treated with Nucleos(t)ide Analogs For > 10 years." Journal of Gastroenterology, vol. 61, no. 7, 2026, p. 990, https://doi.org/10.1007/s00535-026-02415-3.